QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.104.073098v1 311/3/1088    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pinsonneault, J. Articles by Sadée, W. Search for Related Content PubMed PubMed Citation Articles by Pinsonneault, J. Articles by Sadée, W.

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

Genetic Variants of the Human H⁺/Dipeptide Transporter PEPT2: Analysis of Haplotype Functions

Department of Pharmacology Program in Pharmacogenomics, College of Medicine and Public Health, The Ohio State University, Columbus, Ohio (J.P., W.S.); and Molecular Biopharmaceutics, Department of Pharmaceutics, Danish University of Pharmaceutical Sciences, Copenhagen, Denmark (C.U.N.)

PEPT2 is a high-affinity H⁺/dipeptide transporter expressed in kidney, brain, lung, and mammary gland. The physiological role of PEPT2 in kidney is to reabsorb small peptides generated by luminal peptidases. PEPT2 is also a transporter for peptide-like drugs such as penicillins and cephalosporins. We have conducted a haplotype analysis of 27 single nucleotide polymorphisms located in or near exons of the human gene encoding hPEPT2 (SLC15A2), using genotyping data from 247 genomic DNA samples from the Coriell collection. Our analysis reveals that hPEPT2 has a >6-kilobase sequence block with at least 10 abundant polymorphisms in almost complete linkage disequilibrium. As a result, only two main hPEPT2 variants exist (hPEPT2*1 and *2) with several phased amino acid substitutions, present in substantial frequencies in all ethnic groups tested. When expressed in Chinese hamster ovary cells, hPEPT2*1 and *2 displayed similar V_max values for glycyl-sarcosine (Gly-Sar), but they differed significantly in their K_m values (83 ± 16 and 233 ± 38 µM, respectively). Moreover, hPEPT2*1 and *2 differed in their pH sensitivity for H⁺/Gly-Sar transport. In addition, hPEPT2*1 and *2 generated varying levels of mRNA in nine heterozygous kidney tissue samples, including one allele expressing no detectable mRNA, suggesting the presence of cis-acting polymorphisms affecting transcription or mRNA processing. The results indicate that polymorphisms in the gene encoding hPEPT2 can alter substrate transport and therefore could affect drug disposition in vivo.

Address correspondence to: Dr. Julia Pinsonneault, Department of Pharmacology, 333 West 10th Ave., The Ohio State University, Columbus OH 43210-1239. E-mail: pinsonneault.2{at}osu.edu

This article has been cited by other articles:

				D. Wang, H. Chen, K. M. Momary, L. H. Cavallari, J. A. Johnson, and W. Sadee Regulatory polymorphism in vitamin K epoxide reductase complex subunit 1 (VKORC1) affects gene expression and warfarin dose requirement Blood, August 15, 2008; 112(4): 1013 - 1021. [Abstract] [Full Text] [PDF]

				J. A. Williams, T. Andersson, T. B. Andersson, R. Blanchard, M. O. Behm, N. Cohen, T. Edeki, M. Franc, K. M. Hillgren, K. J. Johnson, et al. PhRMA White Paper on ADME Pharmacogenomics J. Clin. Pharmacol., July 1, 2008; 48(7): 849 - 889. [Abstract] [Full Text] [PDF]

				M. Sala-Rabanal, D. D. F. Loo, B. A. Hirayama, and E. M. Wright Molecular mechanism of dipeptide and drug transport by the human renal H+/oligopeptide cotransporter hPEPT2 Am J Physiol Renal Physiol, June 1, 2008; 294(6): F1422 - F1432. [Abstract] [Full Text] [PDF]

				Y. Zhuang and K. L. Adams Extensive Allelic Variation in Gene Expression in Populus F1 Hybrids Genetics, December 1, 2007; 177(4): 1987 - 1996. [Abstract] [Full Text] [PDF]

				H. Shen, S. M. Ocheltree, Y. Hu, R. F. Keep, and D. E. Smith Impact of Genetic Knockout of PEPT2 on Cefadroxil Pharmacokinetics, Renal Tubular Reabsorption, and Brain Penetration in Mice Drug Metab. Dispos., July 1, 2007; 35(7): 1209 - 1216. [Abstract] [Full Text] [PDF]

				J. K. Pinsonneault, A. C. Papp, and W. Sadee Allelic mRNA expression of X-linked monoamine oxidase a (MAOA) in human brain: dissection of epigenetic and genetic factors Hum. Mol. Genet., September 1, 2006; 15(17): 2636 - 2649. [Abstract] [Full Text] [PDF]

				H. Daniel, B. Spanier, G. Kottra, and D. Weitz From Bacteria to Man: Archaic Proton-Dependent Peptide Transporters at Work Physiology, April 1, 2006; 21(2): 93 - 102. [Abstract] [Full Text] [PDF]

				P. Anderle, C. U. Nielsen, J. Pinsonneault, P. L. Krog, B. Brodin, and W. Sadee Genetic Variants of the Human Dipeptide Transporter PEPT1 J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 636 - 646. [Abstract] [Full Text] [PDF]

				O. Q. P. Yin, B. Tomlinson, and M. S. S. Chow Variability in Renal Clearance of Substrates for Renal Transporters in Chinese Subjects J. Clin. Pharmacol., February 1, 2006; 46(2): 157 - 163. [Abstract] [Full Text] [PDF]

				W. Sadee and Z. Dai Pharmacogenetics/genomics and personalized medicine Hum. Mol. Genet., October 15, 2005; 14(suppl_2): R207 - R214. [Abstract] [Full Text] [PDF]

				Y. Zhang, D. Wang, A. D. Johnson, A. C. Papp, and W. Sadee Allelic Expression Imbalance of Human mu Opioid Receptor (OPRM1) Caused by Variant A118G J. Biol. Chem., September 23, 2005; 280(38): 32618 - 32624. [Abstract] [Full Text] [PDF]

				P. M. Bahadduri, V. M. D'Souza, J. K. Pinsonneault, W. Sadee, S. Bao, D. L. Knoell, and P. W. Swaan Functional Characterization of the Peptide Transporter PEPT2 in Primary Cultures of Human Upper Airway Epithelium Am. J. Respir. Cell Mol. Biol., April 1, 2005; 32(4): 319 - 325. [Abstract] [Full Text] [PDF]